Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)
March 08 2019 - 2:36PM
Edgar (US Regulatory)
|
|
|
|
|
|
|
|
|
|
|
U.S. Securities and Exchange Commission
100 F Street, N.E.
|
|
|
|
|
|
Washington, DC 20549
|
March 8, 2019
Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and
Section 13(r) of the Exchange Act
Dear Sirs:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of
1934, as amended, notice is hereby provided that Sanofi has made disclosure pursuant to those provisions in its Annual Report on
Form 20-F
for the year ended December 31, 2018, which was filed with
the Securities and Exchange Commission on March 8, 2019.
Sincerely,
|
|
|
/s/ Alexandra Roger
|
|
Alexandra Roger
|
|
Head of Securities Law and Capital Markets
|
54, rue La
Boétie, 75414 Paris Cedex 8, France - Tél. : +33 (0)1.53.77.40.00 - Fax : +33 (0)1.53.77.41.33 - www.sanofi.com
SANOFI -
Siège social : 54, rue La Boétie, 75008 Paris, France - S.A. au capital de 2 494 224 498 € - 395 030 844 R.C.S. Paris - Code APE 7010 Z - N° intracommunautaire : FR 88395030844
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (PK) (USOTC:SNYNF)
Historical Stock Chart
From Apr 2023 to Apr 2024
